TheHinduBusinessLine
US market heavily reliant on India for Active Pharmaceutical Ingredients and low-cost generics, will struggle to find alternative sources, says Pharmexcil Chairman Namit Joshi…
Read More
Trump tariff on Indian goods will hike essential drugs costs in US: Pharmexcil
US market heavily reliant on India for Active Pharmaceutical Ingredients and low-cost generics, will struggle to find alternative sources, says Pharmexcil Chairman Namit Joshi…